Reported 2 days ago
The article discusses three promising biotech companies—Axsome Therapeutics, Iovance Biotherapeutics, and Viking Therapeutics—that are seen as potential future 'monster stocks.' Axsome is gaining momentum with strong revenue growth, particularly from its depression treatment, Auvelity. Iovance aims to innovate cancer treatment with its tumor-infiltrating lymphocyte therapies, demonstrating rapid sales growth. Viking is making strides in the anti-obesity market with its drug VK2735 and other pipeline products. Each company presents unique opportunities despite potential risks.
Source: YAHOO